According to the European Molecular Genetics Quality Network’s best practice guidelines, the current first-line approach relies on genetic sequencing for COL1A1 and COL1A2 to identify causative variants most commonly found in OI patients. Here, COL1A2 is linked to osteogenesis imperfecta.